Average Co-Inventor Count = 2.81
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Visterra, Inc. (13 from 37 patents)
2. Massachusetts Institute of Technology (8 from 8,369 patents)
3. Momenta Pharmaceuticals, Inc. (6 from 116 patents)
4. Other (1 from 832,680 patents)
28 patents:
1. 12338291 - Humanized antibody molecules to CD138 and uses thereof
2. 12091451 - Method of using antibody molecules to detect a proliferation-inducing ligand (APRIL)
3. 12054539 - Antibody molecules to dengue virus and uses thereof
4. 11945868 - Antibody molecules to CD138 and uses thereof
5. 11136385 - Methods of treating IgA nephropathy by administering an anti-APRIL (a proliferation-inducing ligand) antibody molecule
6. 11059883 - Antibody molecules to dengue virus and uses thereof
7. 10981982 - Nucleic acid molecules encoding antibodies to a proliferation-inducing ligand (APRIL)
8. 10968270 - Antibody molecules to a proliferation-inducing ligand (APRIL)
9. 10954296 - Method of using anti-APRIL (a proliferation-inducing ligand) antibodies to reduce IGA
10. 10385123 - Antibody molecules to a proliferation-inducing ligand (APRIL)
11. 10155806 - Antibody molecules to dengue virus and uses thereof
12. 9921210 - High mannose glycans
13. 9365639 - Antibody molecules to dengue virus and uses thereof
14. 9212217 - Antibody molecules to dengue virus and uses thereof
15. 8846363 - [object Object]